首页> 外国专利> FUNCTIONAL IMMUNOHISTOCHEMICAL CELL CYCLE ANALYSIS AS A PROGNOSTIC INDICATOR FOR CANCER

FUNCTIONAL IMMUNOHISTOCHEMICAL CELL CYCLE ANALYSIS AS A PROGNOSTIC INDICATOR FOR CANCER

机译:功能性免疫组织化学细胞周期分析作为癌症的预后指标

摘要

The present invention relates to a method of determining the presence of a retinoblastoma protein (Rb)-mediated cancerous or pre-cancerous condition in a sample of fixed cells that involves exposing the sample to an antibody that recognizes phosphorylation of serine on the retinoblastoma protein (pS-Rb), and identifying cells in the sample that are recognized by the antibody to pS-Rb, where the recognition of pS-Rb in the sample determines the presence of an Rb-mediated cancerous or pre-cancerous condition. The method also involves identifying the presence of specific cell cycle markers and positive and negative cell cycle regulators to assess the stage of disease progression in a cancer patient having an (Rb)-mediated cancer. The present invention also relates to methods of assessing the efficacy of cancer therapy for an Rb-mediated cancer, determining the mechanism of cell cycle progression in an Rb-mediated cancer, and identifying cells predisposed to developing an Rb-mediated cancerous condition.
机译:本发明涉及一种确定固定细胞样品中是否存在视网膜母细胞瘤蛋白(Rb)介导的癌性或癌前状态的方法,该方法包括将样品暴露于识别视网膜母细胞瘤蛋白上丝氨酸磷酸化的抗体( pS-Rb),并鉴定被pS-Rb抗体识别的样品中的细胞,其中样品中pS-Rb的识别确定Rb介导的癌性或癌前状态的存在。该方法还涉及鉴定特定细胞周期标志物以及阳性和阴性细胞周期调节剂的存在以评估患有(Rb)介导的癌症的癌症患者中疾病进展的阶段。本发明还涉及评估针对Rb介导的癌症的癌症疗法的功效,确定Rb介导的癌症中的细胞周期进程的机制以及鉴定倾向于发展Rb介导的癌性疾病的细胞的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号